This Article Full Text Full Text (PDF) All Versions of this Article: 2003-0091OCv1 30/3/271    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Atochina, E. N. Articles by Gow, A. J. Search for Related Content PubMed PubMed Citation Articles by Atochina, E. N. Articles by Gow, A. J.

Surfactant Protein-D, a Mediator of Innate Lung Immunity, Alters the Products of Nitric Oxide Metabolism

Pulmonary and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia; Children's Hospital of Philadelphia, Division of Neonatology, Philadelphia, Pennsylvania; and Cardiovascular Research Institute and Department of Pediatrics, University of California at San Francisco, San Francisco, California

Address correspondence to: Andrew J. Gow, Ph.D., Children's Hospital of Philadelphia, Abramson Research Center, Rm. 416A, 34th & Civic Center Blvd., Philadelphia, PA 19104. E-mail: Gow{at}email.chop.edu

Surfactant protein (SP)-D, a 43-kD multifunctional collagen-like lectin, is synthesized and secreted by the airway epithelium. SP-D knockout (SP-D [-/-]) mice exhibit an increase in the number and size of airway macrophages, peribronchiolar inflammation, increases in metalloproteinase activity, and development of emphysema. Nitric oxide (NO) is involved in a variety of signaling processes, and because altered NO metabolism has been observed in inflammation, we hypothesized that alterations in its metabolism would underlie the proinflammatory state observed in SP-D deficiency. Examination of the bronchial alveolar lavage (BAL) from SP-D (-/-) mice reveals a significant increase in protein and phospholipid content and total cell count. NO production and inducible NO synthase expression were increased in the BAL; however, there was a decline in S-nitrosothiol (SNO) content in the BAL and a loss of SNO immunoreactivity within the tissue. This decline in SNO was accompanied by an increase in nitrotyrosine staining. We conclude that inflammation that occurs in SP-D deficiency results in an increase in NO production and a shift in the chemistry and targets of NO. We speculate that the proinflammatory response due to SP-D deficiency results, in part, from a disruption of NO-mediated signaling within the innate immune system.

Abbreviations: bronchiolar alveolar lavage, BAL • enzyme-linked immunosorbent assay, ELISA • inducible nitric oxide synthase, iNOS • large aggregate surfactant, LA • matrix metalloproteinase, MMP • nitric oxide, NO • small aggregate surfactant, SA • S-nitrosothiol, SNO • surfactant protein, SP

This article has been cited by other articles:

				D. D. Sin, P. S. Pahlavan, and S.F. P. Man Review: Surfactant protein D: A lung specific biomarker in COPD? Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 65 - 74. [Abstract] [PDF]

				E. N. Atochina-Vasserman, M. F. Beers, H. Kadire, Y. Tomer, A. Inch, P. Scott, C. J. Guo, and A. J. Gow Selective Inhibition of Inducible NO Synthase Activity In Vivo Reverses Inflammatory Abnormalities in Surfactant Protein D-Deficient Mice J. Immunol., December 15, 2007; 179(12): 8090 - 8097. [Abstract] [Full Text] [PDF]

				D. Jain, E. Atochina-Vasserman, H. Kadire, Y. Tomer, A. Inch, P. Scott, R. C. Savani, A. J. Gow, and M. F. Beers SP-D-deficient mice are resistant to hyperoxia Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L861 - L871. [Abstract] [Full Text] [PDF]

				D. E. McClintock, L. B. Ware, M. D. Eisner, N. Wickersham, B. T. Thompson, M. A. Matthay, and the National Heart, Lung, and Blood Institute ARDS Higher Urine Nitric Oxide Is Associated with Improved Outcomes in Patients with Acute Lung Injury Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 256 - 262. [Abstract] [Full Text] [PDF]

				A. J. Gow The biological chemistry of nitric oxide as it pertains to the extrapulmonary effects of inhaled nitric oxide. Proceedings of the ATS, January 1, 2006; 3(2): 150 - 152. [Abstract] [Full Text] [PDF]

				M. Ochs, L. Knudsen, L. Allen, A. Stumbaugh, S. Levitt, J. R. Nyengaard, and S. Hawgood GM-CSF mediates alveolar epithelial type II cell changes, but not emphysema-like pathology, in SP-D-deficient mice Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1333 - L1341. [Abstract] [Full Text] [PDF]

				J. R. Lancaster Jr. and B. Gaston NO and nitrosothiols: spatial confinement and free diffusion Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L465 - L466. [Full Text] [PDF]

				A. J. Gow, C. R. Farkouh, D. A. Munson, M. A. Posencheg, and H. Ischiropoulos Biological significance of nitric oxide-mediated protein modifications Am J Physiol Lung Cell Mol Physiol, August 1, 2004; 287(2): L262 - L268. [Abstract] [Full Text] [PDF]